Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience.
AuthorsGowda, Raghavendra V
Henk, J Michael
Mais, Kathleen L
Sykes, Andrew J
Slevin, Nicholas J
AffiliationDepartment of Clinical Oncology, Christie Hospital, Wilmslow Road, Manchester, M20 4BX, UK.
MetadataShow full item record
AbstractBACKGROUND AND PURPOSE: Radiotherapy for laryngeal carcinoma is conventionally given over a 6-7-week period. However, in a number of UK centres early lesions are treated over 3 weeks. We review recent results of this policy and discuss the reasons why short treatment times may be advantageous. MATERIALS AND METHODS: Two hundred patients (100 from each centre) with T1 glottic invasive squamous cell carcinoma treated with definitive radiotherapy between 1989 and 1997 were analysed. The median age was 68 years. All patients received once daily fractionation, 5 days a week to a total tumour dose of 50.0-52.5 Gy in 16 fractions over 21 days; the fraction size ranged from 3.12 to 3.28 Gy. The median follow-up period was 5 years and 10 months. RESULTS: The 5-year local control rates with radiotherapy for the whole group was 93%; there were 14 recurrences of which seven were salvaged by laryngectomy giving an ultimate local control of 96%. The 5-year overall survival was 80% and cause specific survival at 5 years was 97%. Univariate analysis revealed that T1 substaging (P=0.82) and anterior commissure involvement (P=0.47) did not significantly influence local control. A severe late radiation complication was seen in only one patient who continued to smoke heavily after treatment. There were no severe acute complications. CONCLUSIONS: Once daily radiotherapy over 3 weeks gives excellent local control in patients with T1 glottic squamous-cell carcinoma and has a low rate of severe complications. The short overall treatment time and large fraction size may be advantageous in radiotherapy of these well-differentiated tumours.
CitationThree weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience. 2003, 68 (2):105-11 Radiother Oncol
JournalRadiotherapy and Oncology
- Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
- Authors: Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM, Phillips TL
- Issue date: 1997 Aug 1
- Definitive radiotherapy for T1 glottic squamous cell carcinoma: a 15-year Cruces University Hospital experience.
- Authors: Cacicedo J, Casquero F, del Hoyo O, Gomez-Iturriaga A, Martinez-Indart L, Lopez JL, Bilbao P
- Issue date: 2013 Nov
- Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
- Authors: Zouhair A, Azria D, Coucke P, Matzinger O, Bron L, Moeckli R, Do HP, Mirimanoff RO, Ozsahin M
- Issue date: 2004 Feb
- Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience.
- Authors: Reddy SP, Hong RL, Nagda S, Emami B
- Issue date: 2007 Dec 1
- Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
- Authors: Ricciardelli EJ, Weymuller EA Jr, Koh WJ, Austin-Seymour M, DeSautel MG, Laramore GE
- Issue date: 1994 Jul